Skip to the page

Data / Form D filings / Bright Peak Therapeutics, Inc.

Bright Peak Therapeutics, Inc.: Form D filings

Bright Peak Therapeutics, Inc., a company in Del Mar, CA, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on June 11, 2024, reports $90 million sold of a $90 million offering to 21 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2010 Jimmy Durante Blvd, Suite 150, Del Mar, CA, 92014
Phone
(626) 298-0609
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1813343

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 11, 2024New notice$89,999,991$89,999,99121May 7, 2024sec.gov
Jun 11, 2021New notice$106,500,011$106,500,01117May 14, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Bertolt KreftExecutive Officer
Laura ShawverDirector
Tom WoiwodeDirector
Vijaya PattabiramanExecutive Officer
Matthew RobbinsExecutive Officer
Leena GandhiDirector
Asish XavierDirector
Christine SiuDirector
Fredrik WiklundExecutive Officer, Director
Emily MinkowDirector
Jon WiggintonExecutive Officer
Jacob ChackoDirector

Other companies in California that filed recently

Every Form D from the week of Jun 10, 2024 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Bright Peak Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.